XML 50 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Balance Sheet Components (Tables)
12 Months Ended
Dec. 31, 2017
Balance Sheet Components  
Schedule of cash equivalents and available-for-sale securities

Cash equivalents and available-for-sale securities consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2017

 

 

Amortized

 

Gross Unrealized

 

 

 

    

Cost

    

Gains

    

Losses

    

Fair Value

Money market funds

 

$

48,704

 

$

 —

  

$

 

$

48,704

Corporate bonds

 

 

6,254

 

 

 —

  

 

(7)

 

 

6,247

Commercial paper

 

 

58,524

 

 

 —

  

 

 

 

58,524

Government bonds

 

 

40,428

 

 

 —

  

 

(125)

 

 

40,303

Total cash equivalents and available-for-sale securities

 

$

153,910

 

$

 —

  

$

(132)

 

$

153,778

Classified as:

 

 

 

  

 

 

  

 

 

  

 

 

Cash equivalents

 

 

 

  

 

 

  

 

 

  

$

104,348

Available-for-sale securities - current

 

 

 

  

 

 

  

 

 

  

 

37,972

Available-for-sale securities - noncurrent

 

 

 

  

 

 

  

 

 

  

 

11,458

Total cash equivalents and available-for-sale securities

 

 

 

  

 

 

  

 

 

  

$

153,778

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016

 

 

Amortized

 

Gross Unrealized

 

 

 

    

Cost

    

Gains

    

Losses

    

Fair Value

Money market funds

 

$

11,270

 

$

 —

  

$

 

$

11,270

Corporate bonds

 

 

21,886

 

 

 —

  

 

(45)

 

 

21,841

Commercial paper

 

 

10,769

 

 

 —

  

 

 

 

10,769

Government bonds

 

 

41,316

 

 

 2

  

 

(29)

 

 

41,289

Total cash equivalents and available-for-sale securities

 

$

85,241

 

$

 2

  

$

(74)

 

$

85,169

Classified as:

 

 

 

  

 

 

  

 

 

  

 

 

Cash equivalents

 

 

 

  

 

 

  

 

 

  

$

18,504

Available-for-sale securities - current

 

 

 

  

 

 

  

 

 

  

 

56,515

  Available-for-sale securities - noncurrent

 

 

 

  

 

 

  

 

 

  

 

10,150

Total cash equivalents and available-for-sale securities

 

 

 

  

 

 

  

 

 

  

$

85,169

 

Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

December 31, 

 

    

2017

    

2016

Prepaid clinical and research related expenses

 

$

2,324

 

$

2,488

Prepaid insurance

 

 

378

 

 

408

Other

 

 

1,071

 

 

498

Prepaid expenses and other current assets

 

$

3,773

 

$

3,394

 

Summary of Property and Equipment Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

December 31,

 

    

2017

    

2016

Laboratory equipment

 

$

2,177

 

$

1,650

Furniture and computer equipment

 

 

270

 

 

163

Leasehold improvements

 

 

26

 

 

62

Total property and equipment

 

 

2,473

 

 

1,875

Less: accumulated depreciation and amortization

 

 

(1,594)

 

 

(1,313)

Property and equipment, net

 

$

879

 

$

562

 

Summary of Accrued Expenses and Other Payables

Accrued expenses and other payables consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

December 31, 

 

    

2017

    

2016

Accrued clinical and research related expenses

 

$

6,437

 

$

3,617

Accrued employee related expenses

 

 

2,718

 

 

1,420

Accrued professional service fees

 

 

267

 

 

115

Other

 

 

124

 

 

120

Accrued expenses and other payables

 

$

9,546

 

$

5,272